• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


asco

  1. No Offense, but

    This is my second ASCO and I have to say, everyone I have ever encountered from BMS is a giant tool. That's all.
  2. ASCO

    Any actual employees here? Will Dendreon have any definitive data on their P-11 trial? Don't need to know positive or negative.